Company intelligence / Profile preview
JW Pharmaceutical Corporation
Gwacheon-si, Seoul, South Koreajw-pharma.co.kr ↗
- Ownership
- Public · 001060
- Employees
- ~1064
- Development stage
- Commercial
01
Overview
The company recently presented preclinical data for a novel AML (Acute Myeloid Leukemia) therapy candidate at AACR 2025 through C&C Research Laboratories[1]
- Therapeutic areas
- GastroenterologyCardiovascularOphthalmologyImmunologyOncology
- Modalities
- Small moleculesbiologics
- Industry
- Biotech
02
Drug pipeline
45 assets44 more assets in the full pipeline.
03
Partnerships
Progen Co., Ltd.Yuhan CorporationSL Bigen Co., Ltd.[3]
04
Financials
- Market cap
- $379.9M
- Total revenue
- $572.4M
- Enterprise value
- $388.9M
Beyond the preview
Go deeper on JW Pharmaceutical Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JW Pharmaceutical Corporation.